Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - ALNYLAM PHARMACEUTICALS, INC. | b87804e10vq.htm |
| EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | b87804exv32w1.htm |
| EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | b87804exv31w2.htm |
| EX-10.1 - EX-10.1 - ALNYLAM PHARMACEUTICALS, INC. | b87804exv10w1.htm |
| EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | b87804exv32w2.htm |
| EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | b87804exv31w1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC. | Financial_Report.xls |
Exhibit 12
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES
(dollars in thousands)
(dollars in thousands)
| Nine Months Ended | Three Months Ended | |||||||||||||||||||||||||||
| September 30, | September 30, | Fiscal Year Ended December 31, | ||||||||||||||||||||||||||
| 2011 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||||
Earnings (loss): |
||||||||||||||||||||||||||||
Pre-tax loss from continuing operations before adjustment for loss from equity investee |
$ | (40,795 | ) | $ | (12,770 | ) | $ | (35,362 | ) | $ | (42,098 | ) | $ | (16,240 | ) | $ | (79,146 | ) | $ | (34,608 | ) | |||||||
add: Fixed charges (see below) |
905 | 302 | 1,207 | 712 | 1,115 | 1,553 | 1,532 | |||||||||||||||||||||
Pre-tax income (loss) from continuing operations before adjustment for income/loss
from equity investees plus fixed charges |
$ | (39,890 | ) | $ | (12,468 | ) | $ | (34,155 | ) | $ | (41,386 | ) | $ | (15,125 | ) | $ | (77,593 | ) | $ | (33,076 | ) | |||||||
Fixed charges: |
||||||||||||||||||||||||||||
Interest expense on indebtedness |
$ | — | $ | — | $ | — | $ | — | $ | 872 | $ | 1,083 | $ | 1,029 | ||||||||||||||
Interest expense on portion of rent expense representative of interest |
905 | 302 | 1,207 | 712 | 243 | 470 | 503 | |||||||||||||||||||||
Total fixed charges |
$ | 905 | $ | 302 | $ | 1,207 | $ | 712 | $ | 1,115 | $ | 1,553 | $ | 1,532 | ||||||||||||||
Ratio of earnings to fixed charges |
— | — | — | — | — | — | — | |||||||||||||||||||||
Deficiency of earnings available to cover fixed charges |
$ | (40,795 | ) | $ | (12,770 | ) | $ | (35,362 | ) | $ | (42,098 | ) | $ | (16,240 | ) | $ | (79,146 | ) | $ | (34,608 | ) | |||||||